Literature DB >> 7196690

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration.

D R Rosing, J R Condit, B J Maron, K M Kent, M B Leon, R O Bonow, L C Lipson, S E Epstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7196690     DOI： 10.1016/0002-9149(81)90086-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  16 in total

1.  Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium.

Authors:  R A Brown; M M Lee; A M Sundareson; D J Woodbury; A O Savage
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 2.  The frontiers of cardiomyopathy.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1982-07

Review 3.  Pharmacologic treatment of hypertrophic cardiomyopathy: beta-blockade or calcium blockade or what?

Authors:  J F Goodwin
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

4.  Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients.

Authors:  F Pelliccia; C Cianfrocca; F Romeo; A Reale
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

5.  Surgical management of hypertrophic cardiomyopathy in 2007: what is new?

Authors:  Morgan L Brown; Hartzell V Schaff
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

6.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

7.  Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris.

Authors:  N S Khurmi; C W Robinson; M J O'Hara; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.

Authors:  D M Anderson; G L Raff; T A Ports; B H Brundage; W W Parmley; K Chatterjee
Journal:  Br Heart J       Date:  1984-05

9.  Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; B S Jenkins; M M Webb-Peploe
Journal:  Br Heart J       Date:  1986-12

10.  Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil.

Authors:  S J Roth; C B Porter; L A Latson
Journal:  Tex Heart Inst J       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.